Neuralink to implant its brain chips in Canada
- Neuralink has received approval to begin its first clinical trial in Canada, which signifies an expansion of its testing outside the United States.
- The University Health Network in Toronto will host the Canadian trial named CAN-PRIME, assessing safety and functionality.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left0Leaning Right2Center1Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
C 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage